These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25799831)

  • 1. [The use of stepwise antibacterial therapy of community-acquired pneumonia].
    Iashchenko AV; Sinopal'nikov AI
    Klin Med (Mosk); 2014; 92(6):53-6. PubMed ID: 25799831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibacterial therapy of outhospital pneumonia in military treatment-prophylactic institutions].
    Sinopal'nikov AI; Rachina SA; Iashchenko AV; Shal' EP
    Voen Med Zh; 2009 Feb; 330(2):14-20. PubMed ID: 19351019
    [No Abstract]   [Full Text] [Related]  

  • 3. The halo effect of adherence to guidelines extends to patients with severe community-acquired pneumonia requiring admission to an intensive care unit.
    Marrie TJ
    Clin Infect Dis; 2005 Dec; 41(12):1717-9. PubMed ID: 16288393
    [No Abstract]   [Full Text] [Related]  

  • 4. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
    Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
    Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community-acquired pneumonia.
    Niederman MS
    Isr Med Assoc J; 2003 Feb; 5(2):133-8. PubMed ID: 12674669
    [No Abstract]   [Full Text] [Related]  

  • 6. New guidelines for the management of adult community-acquired pneumonia.
    Armitage K; Woodhead M
    Curr Opin Infect Dis; 2007 Apr; 20(2):170-6. PubMed ID: 17496576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapeutic aspect of antibiotic therapy during acute community-acquired pneumonia in adults at the University Hospital of Cocody (Abidjan).
    Kouakou-Siransy G; Horo K; Effo E; Kamenan A; N'guessan-Irié G; Boko-Kouassi A; Aka-Anguy E; Die Kakou H
    Int J Clin Pharmacol Ther; 2015 Nov; 53(11):940-6. PubMed ID: 26413732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An economic and outcomes assessment of first-line monotherapy in the treatment of community-acquired pneumonia within managed care.
    Skrepnek GH; Armstrong EP; Malone DC; Ramachandran S
    Curr Med Res Opin; 2005 Feb; 21(2):261-70. PubMed ID: 15801997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resource use and cost of care for patients hospitalised with community acquired pneumonia: impact of adherence to infectious diseases society of america guidelines.
    Orrick JJ; Segal R; Johns TE; Russell W; Wang F; Yin DD
    Pharmacoeconomics; 2004; 22(11):751-7. PubMed ID: 15250752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe community-acquired pneumonia in adults: current antimicrobial chemotherapy.
    Niven DJ; Laupland KB
    Expert Rev Anti Infect Ther; 2009 Feb; 7(1):69-81. PubMed ID: 19622058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed administration of antibiotics and atypical presentation in community-acquired pneumonia.
    Waterer GW; Kessler LA; Wunderink RG
    Chest; 2006 Jul; 130(1):11-5. PubMed ID: 16840376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding variation in quality of antibiotic use for community-acquired pneumonia: effect of patient, professional and hospital factors.
    Schouten JA; Hulscher ME; Kullberg BJ; Cox A; Gyssens IC; van der Meer JW; Grol RP
    J Antimicrob Chemother; 2005 Sep; 56(3):575-82. PubMed ID: 16049096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical and economic aspects of treating community-acquired pneumonias].
    Tiurin VP; Dmitriev IuK; Duganov VK; Bogdanov MB
    Voen Med Zh; 2000 Apr; 321(4):28-31. PubMed ID: 10860468
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of community-acquired pneumonia in adults.
    Working Group of the South African Thoracic Society
    S Afr Med J; 2002 Aug; 92(8 Pt 2):647-55. PubMed ID: 12244941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tailored interventions to improve antibiotic use for lower respiratory tract infections in hospitals: a cluster-randomized, controlled trial.
    Schouten JA; Hulscher ME; Trap-Liefers J; Akkermans RP; Kullberg BJ; Grol RP; van der Meer JW
    Clin Infect Dis; 2007 Apr; 44(7):931-41. PubMed ID: 17342644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Estimation of the clinical and pharmacoeconomic efficiency of treatment in patients with community-acquired pneumonia with third-generation cephalosporins].
    Starodubtseva OI; Vakhrushev IaM
    Probl Tuberk Bolezn Legk; 2009; (6):28-9. PubMed ID: 19642570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy for severe community-acquired pneumonia.
    Berk SL
    Clin Infect Dis; 1997 Jul; 25(1):168-9. PubMed ID: 9243063
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hospitalist perspective on treatment of community-acquired bacterial pneumonia.
    Amin AN; Cerceo EA; Deitelzweig SB; Pile JC; Rosenberg DJ; Sherman BM
    Postgrad Med; 2014 Mar; 126(2):18-29. PubMed ID: 24685965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community acquired bacterial pneumonia.
    Anevlavis S; Bouros D
    Expert Opin Pharmacother; 2010 Feb; 11(3):361-74. PubMed ID: 20085502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.